Two antigenically similar subtypes of equine herpesvirus 1 (EHV-1) cause disease in horses. A procedure for rapid differentiation of the two EHV-1 subtypes with monoclonal antibodies was developed. Subtype-specific pools of monoclonal antibodies were constructed, characterized, and used in enzyme immunofiltration and indirect immunofluorescence assays to subtype 50 epizootiologically unrelated field isolates of EHV-1. Both assays allowed accurate subtype identification of each EHV-1 isolate with the monoclonal antibody pools. The subtyping procedures were simple and amenable to typing many isolates at one time and permitted unambiguous EHV-1 subtype identification within 3 h after isolation of the virus in tissue culture.
Infection of horses by equine herpesvirus 1 (EHV-1) is a leading cause of both morbidity and mortality in horse populations and a source of serious economic loss to the horse breeding industry (3, 6) . EHV-1 infections may result in epizootics of respiratory tract disease, abortion, and a paralytic disorder of the central nervous system (3, 5, 7) . Although all EHV-1 isolates are antigenically similar (3), several workers have reported genetic and serological differences among strains of EHV-1 and have distinguished two molecular subtypes (1, 4, (13) (14) (15) (16) . The two subtypes of EHV-1 can be differentiated by serological tests and by major differences in their restriction endonuclease cleavage patterns. However, subtyping techniques based on polyclonal antisera are hampered by the extensive cross-reactivity of the antisera, and the DNA fingerprinting technique requires time, specialized equipment, and technical expertise. The development of alternative laboratory methods that are simple, rapid, and unambiguous for the determination of EHV-1 subtype would therefore be desirable.
Other closely related herpesviruses have been differentiated by rapid serological analyses with monoclonal antibodies (2, (10) (11) (12) . The objective of the investigation described in this report was to construct subtype-specific monoclonal antibodies to EHV-1 for use in the rapid subtyping of clinical isolates from field outbreaks of EHV-1-related disease.
MATERIALS AND METHODS
Cells and viruses. Equine dermal fibroblast (KyED) cells were used to propagate EHV-1 isolates. The origin of the virus strains used in this study has been described previously (1, 16 For the production of hybrid cell lines secreting subtype 2-specific monoclonal antibodies, the supernatant fluids from growing colonies were screened in an enzyme-linked immunosorbent assay against virus isolates (Army 183 and Kentucky T2) representing both subtypes of EHV-1. Of 341 wells that were planted, 29 of the wells contained antibodies to both subtype strains, whereas 40 wells contained subtype 2-specific antibodies. Culture fluids from 10 of the 40 wells contained high levels of antibody against the subtype 2 strain, and these hybrids were cloned by limiting dilution (9) . A total of eight stable hybrid cell lines which secreted subtype 2-specific monoclonal antibodies were isolated.
Screening anti-EHV-1 monoclonal antibodies for subtype specificity. An enzyme immunofiltration assay against 20 EHV-1 isolates was used to determine which of the four subtype 1-and eight subtype 2-specific monoclonal antibodies would be suitable for typing field isolates of EHV-1. The EHV-1 isolates chosen for this initial screening with the subtype-specific monoclonal antibodies were unrelated and diverse with regard to year, farm where isolated, and DNA fingerprint pattern (1) . No neutralization of homologous or heterologous virus was observed for any of the six monoclonal antibodies in the presence or absence of guinea pig complement.
Use of monoclonal antibodies for subtyping EHV-1 isolates. Two subtype-specific pools of monoclonal antibodies were created by combining ascites preparations of three monoclonal antibodies for each pool. The proportions of individual antibodies composing each pool were based on the immunofiltration titers of each ascites preparation. The endpoint titers of subtype-specific monoclonal antibodies to homologous virus-infected cells were as follows: 13B2, 30,000; 16C12, 24,000; 16H9, 32,000; 19B8, 192,000; 20F3, 192,000; 21C5, 383,000. Titers to heterologous virus-infected cells in all cases were less than 1,500. Normal ascites had endpoint titers of less than 1,000 to both subtypes of target cells. Table 2 shows the results of subtyping 50 EHV-1 isolates with the two pools of subtype-specific monoclonal antibodies. Both antibody pools gave significantly higher absorbance readings with homologous EHV-1 isolates than with isolates of the heterologous subtype. The variation between duplicate assay samples was not significant (F test result, a = 0.152) in three of the four data groups. However, the difference between duplicate assay samples (32.56 versus 28.40, sum of replicates 1 and 2) for subtype 1-specific monoclonal antibody pool and subtype 1 EHV-1 isolates was significant (F test result, a = 0.0005). Although significant, the magnitude of the difference between duplicates was small (1.15) as compared with an 8.13-fold difference be- T19  120  320  240  <10  <10  <10  T93  80  240  60  <10  <10  <10  T186  80  240  80  <10  <10  <10  T203  120  480  80  <10  <10  <10  T246  65  320  120  <10  <10  <10  T391  120  240  80  <10  <10  20  T426  120  440  160  <10  <10  <10  T453  120  320  240  <10  <10  20  T495  120  320  160  <10  <10  <10  A183  480 2,560  320  NDc  ND  ND   Subtype 2   T3  <10  <10  <10  320  480  240  T45  <10  <10  <10  320  480  480  T85  <10  <10  <10  480  640  640  T161  <10  <10  <10  240  640  320  T200  <10  <10  <10  240  480  640  T213  <10  <10  <10  120  480  1,280  T288  <10  <10  <10  240  560  240  T369  <10  <10  <10  320  480  960  T463  <10  <10  <10  320  800  640  T2  ND  ND  ND  240  320  1,280 a The virus isolates were recovered from 21 epizootiologically unrelated outbreaks of EHV-1 abortion or respiratory tract disease that occurred in U.S. horses between 1941 and 1983. The isolates were subtyped by restriction endonuclease analysis as described previously (1) .
b Each value represents the mean of two replicates expressed as the reciprocal of the highest dilution of hybrid cell culture fluids resulting in an A490 of 0.3 or more in an enzyme immunofiltration assay with virus-infected KyED cells as antigen. ' Table 2 ). The EHV-1 isolates listed in Table 2 originated from epizootiologically unrelated outbreaks of EHV-1 abortion and respiratory tract disease that occurred in U.S. horses during the past 20 years (1). All 50 EHV-1 isolates were correctly typed with the immunofiltration assay.
The immunofluorescence assay also accurately indicated the subtype of EHV-1 infecting KyED cells (Table 2 ). Both pools gave a cytoplasmic fluorescence that can be described as a pinpoint dot pattern. This pattern of immunofluorescence has also been reported for monoclonal antibodies reacting to HSV-2-infected cells (11) . The subtype 2 pool of monoclonal antibodies showed weak fluorescence with many subtype 2 strains of EHV-1 when used at a 1:10,000 dilution. The intensity of fluorescence was increased when a lower dilution of monoclonal antibody (1:3,000) was applied.
DISCUSSION
This report describes the production and use of subtypespecific monoclonal antibody pools to type field isolates of EHV-1. The use of a pool rather than single monoclonal antibodies diminishes the chance that an isolate will escape immune recognition as a result of a loss or alteration in the antigenic determinant that is recognized by one particular antibody.
The enzyme immunofiltration and indirect immunofluorescence assays were used to rapidly subtype EHV-1 isolates. In both assays, the two EHV-1 subtype-specific monoclonal antibody pools exhibited a distinct difference in the strength of their reaction with EHV-1 isolates of the homologous subtype as compared with that exhibited by isolates belonging to the heterologous subtype. Inspection of the range and mean values exhibited in the immunofiltration assay ( 
